Search research articles
Contact Us
Filters
Showing results (41-50 of 79) with videos related to
Page
of 8
Sort By:
Blood Advances
|
June 8, 2022
Racial disparities in access to alternative donor allografts persist in the era of "donors for all"
Warren B Fingrut, Boglarka Gyurkocza, Eric Davis, et al.
Blood Advances
|
April 26, 2024
High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention
Noa G Holtzman, Lauren M Curtis, Rachel B Salit, et al.
Transplantation and Cellular Therapy
|
October 3, 2025
Post-Transplant Cyclophosphamide Improves Survival in HLA-DPB1 Mismatched Unrelated Donor Allogeneic Transplantation
Shannon R McCurdy, Scott R Solomon, Brian C Shaffer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 28, 2017
Impact of Toxicity on Survival for Older Adult Patients after CD34<sup>+</sup> Selected Allogeneic Hematopoietic Stem Cell Transplantation
Gunjan L Shah, Michael Scordo, Satyajit Kosuri, et al.
Blood Advances
|
October 6, 2025
Matched unrelated vs haploidentical donor hematopoietic cell transplantation using posttransplant cyclophosphamide
Dipenkumar Modi, Yosra M Aljawai, Todd E DeFor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2024
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors
Brian C Shaffer, Mahasweta Gooptu, Todd E DeFor, et al.
American Journal of Hematology
|
September 9, 2023
Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia
Karthik Nath, Jasme Lee, Theresa A Elko, et al.
Cancer Discovery
|
January 9, 2025
Nonselective β-Adrenergic Receptor Inhibitors Impair Hematopoietic Regeneration in Mice and Humans after Hematopoietic Cell Transplants
Jinsuke Nishino, Wenhuo Hu, Ashwin Kishtagari, et al.
American Journal of Hematology
|
March 2, 2021
The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy
Brian J Ball, Meier Hsu, Sean M Devlin, et al.
Blood Advances
|
May 27, 2025
Phase 2 trial of cyclosporine-A, mycophenolate mofetil, and tocilizumab GVHD prophylaxis in cord blood transplantation
Ioannis Politikos, Samantha Brown, Joshua A Fein, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 79) with videos related to
Sort By:
Page
of 8
Blood Advances
|
June 8, 2022
Racial disparities in access to alternative donor allografts persist in the era of "donors for all"
Warren B Fingrut, Boglarka Gyurkocza, Eric Davis, et al.
Blood Advances
|
April 26, 2024
High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention
Noa G Holtzman, Lauren M Curtis, Rachel B Salit, et al.
Transplantation and Cellular Therapy
|
October 3, 2025
Post-Transplant Cyclophosphamide Improves Survival in HLA-DPB1 Mismatched Unrelated Donor Allogeneic Transplantation
Shannon R McCurdy, Scott R Solomon, Brian C Shaffer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 28, 2017
Impact of Toxicity on Survival for Older Adult Patients after CD34<sup>+</sup> Selected Allogeneic Hematopoietic Stem Cell Transplantation
Gunjan L Shah, Michael Scordo, Satyajit Kosuri, et al.
Blood Advances
|
October 6, 2025
Matched unrelated vs haploidentical donor hematopoietic cell transplantation using posttransplant cyclophosphamide
Dipenkumar Modi, Yosra M Aljawai, Todd E DeFor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2024
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors
Brian C Shaffer, Mahasweta Gooptu, Todd E DeFor, et al.
American Journal of Hematology
|
September 9, 2023
Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia
Karthik Nath, Jasme Lee, Theresa A Elko, et al.
Cancer Discovery
|
January 9, 2025
Nonselective β-Adrenergic Receptor Inhibitors Impair Hematopoietic Regeneration in Mice and Humans after Hematopoietic Cell Transplants
Jinsuke Nishino, Wenhuo Hu, Ashwin Kishtagari, et al.
American Journal of Hematology
|
March 2, 2021
The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy
Brian J Ball, Meier Hsu, Sean M Devlin, et al.
Blood Advances
|
May 27, 2025
Phase 2 trial of cyclosporine-A, mycophenolate mofetil, and tocilizumab GVHD prophylaxis in cord blood transplantation
Ioannis Politikos, Samantha Brown, Joshua A Fein, et al.
Page
of 8